Serostim 6mg?

What is Serostim 6mg, and how does it work?

Serostim is a human growth hormone (HGH) formulation that was first approved by the FDA in 1996 [4]. It is primarily used to treat short bowel syndrome (SBS), a condition where a large portion of the small intestine is missing or not functioning properly, leading to malabsorption of nutrients [1]. Serostim is administered via injection, typically 3 times a week, and comes in 5mg and 6mg vial strengths [2].

How long has Serostim been on the market, and are patents expiring?

According to DrugPatentWatch.com, the patent for Serostim (6mg vial) expired in the USA in 2015, and generic versions of the drug have been available since then [3]. This has led to increased competition in the market, making the drug more affordable for patients.

What are the potential side effects of Serostim 6mg?

As with any medication, Serostim 6mg can cause side effects, including injection site reactions, diarrhea, abdominal pain, and changes in blood sugar levels [2]. Patients should closely monitor their blood pressure, blood sugar levels, and lipid profiles while taking the medication.

How does Serostim 6mg compare to other HGH formulations?

Serostim 6mg is one of several HGH formulations, and its efficacy and safety profile are comparable to other products in the same class, such as Norditropin and Omnitrope [1]. However, each preparation may have unique characteristics and dosage requirements.

When does exclusivity expire for Serostim 6mg in other countries?

While the US patent for Serostim (6mg vial) expired in 2015, the drug's exclusivity status in other countries has not been publicly disclosed.

Sources:

[1] Serostim Product Label. Eli Lilly and Company.
[2] US FDA approval letter for Serostim (6mg vial). 1996.
[3] DrugPatentWatch.com, Serostim (6mg vial).
[4] Serostim (6mg vial) prescribing information. Eli Lilly and Company.